Related Experiment Video

Updated: Sep 18, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Benzodiazepine-resistant epilepsy: unraveling molecular mechanisms and developing multimodal therapeutic strategies

Yanqiu Huang¹, Yangfan Zhang¹, Yi Liang²

¹School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Frontiers in Neurology

|June 23, 2025

Abstract:

Epilepsy is one of the most common nervous system diseases, which is characterized by recurrent seizures caused by abnormal neuronal discharges in the brain. Drug-resistant epilepsy (DRE) brings great challenges to clinical treatment. Benzodiazepines (BZDs), as the first-line treatment for acute seizures and Status Epilepticus (SE), are widely used because of their potent inhibitory neuromodulation by regulating γ-aminobutyric acid-A(GABA_A) receptors. However, long-term use of BZDs may induce drug resistance, leading to a significant decrease in efficacy and increasing the difficulty of treatment. This study begins with the definition of BZDs-resistant epilepsy. It explores the underlying resistance mechanisms, including the down-regulation, decreased activity, and structural changes of GABA_A receptors, synapse and neural network remodeling, genetic variation in drug metabolism, and the effects of drug efflux mechanisms. In addition, combined with clinical practice and research progress, this study evaluates the effectiveness and potential of drug combination therapies, personalized treatments, and new treatment methods, highlighting the advantages of simultaneous multi-drug therapy in controlling drug-resistant epilepsy. Further research on the mechanisms of BZDs resistance and optimization of treatment strategies can not only improve the therapeutic effect of drug-resistant epilepsy but also provide a scientific basis for the development of antiepileptic drugs in the future.

Insights

Drug-resistant epilepsy (DRE) poses treatment challenges. Benzodiazepine resistance mechanisms involve GABA-A receptor changes and genetic factors, suggesting combination therapies may improve outcomes.

Area of Science:

Neuroscience
Pharmacology
Clinical Medicine

Background:

Epilepsy is a common neurological disorder characterized by recurrent seizures.
Drug-resistant epilepsy (DRE) presents significant clinical challenges.
Benzodiazepines (BZDs) are first-line treatments for seizures but can lose efficacy over time due to resistance.

Purpose of the Study:

To define Benzodiazepine-resistant epilepsy (BZD-RE).
To explore the mechanisms underlying BZD resistance in epilepsy.
To evaluate novel therapeutic strategies for DRE.

Main Methods:

Review of literature on BZD resistance mechanisms in epilepsy.
Analysis of GABA-A receptor function, synaptic plasticity, and genetic factors.
Evaluation of clinical data and research on combination therapies and personalized treatments.

Main Results:

BZD resistance involves GABA-A receptor down-regulation/dysfunction, neural network alterations, genetic variations in drug metabolism, and enhanced drug efflux.
Combined drug therapies show promise for managing DRE.
Personalized treatment approaches and new therapeutic modalities are being explored.

Conclusions:

Understanding BZD resistance mechanisms is crucial for improving DRE treatment.
Multi-drug combination therapy offers advantages in controlling DRE.
Further research will inform the development of more effective antiepileptic drugs and strategies.

Read full analysis

Keywords:

benzodiazepines drug resistance epilepsy seizure treatment strategies

More Related Videos

Pentylenetetrazole-Induced Kindling Mouse Model

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Epilepsy and Seizures: Overview

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

Sedatives and Hypnotics Drugs: Benzodiazepines

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

Articles linked to this work by shared authors, journal, and citation graph.

Proteome-wide profiling of lysine β-hydroxybutyrylation in Reynoutria japonica (Huzhang) and its dynamics under hydrogen sulfide stress.

Plant physiology and biochemistry : PPB·2026

Convergent latitudinal erosion of circadian systems in a rapidly diversifying order of fishes.

PLoS genetics·2026

Cardiovascular-Kidney-Metabolic Syndrome in neurological and psychiatric disorders: a large multi-national cohort study.

Brain, behavior, and immunity·2026

Comparative diagnostic performance and stability of deep learning- and CFD-based CT-FFR across vessels, cardiac phases, and centers.

Frontiers in cardiovascular medicine·2026

Beyond Fish in Formation: A Two-Tier Approach for Biomechanical Studies of Collective Movement.

Integrative and comparative biology·2026

Joint association of Insulin resistance and frailty index with incident ASCVD and MACE in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a multi-cohort study.

Cardiovascular diabetology·2026

See all related articles